John Cruz

3.3k total citations
45 papers, 2.6k citations indexed

About

John Cruz is a scholar working on Immunology, Epidemiology and Virology. According to data from OpenAlex, John Cruz has authored 45 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Immunology, 25 papers in Epidemiology and 16 papers in Virology. Recurrent topics in John Cruz's work include Influenza Virus Research Studies (18 papers), Immunotherapy and Immune Responses (15 papers) and Poxvirus research and outbreaks (13 papers). John Cruz is often cited by papers focused on Influenza Virus Research Studies (18 papers), Immunotherapy and Immune Responses (15 papers) and Poxvirus research and outbreaks (13 papers). John Cruz collaborates with scholars based in United States, Australia and Puerto Rico. John Cruz's co-authors include Francis A. Ennis, Masanori Terajima, Julie Jameson, Mary Dawn T. Co, Alan L. Rothman, Jeffrey S. Kennedy, Elizabeth D. Kilpatrick, Frederick Koster, Patrick C. Wilson and David J. McClain and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Nature Medicine.

In The Last Decade

John Cruz

44 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John Cruz United States	29	1.3k	1.2k	812	793	658	45	2.6k
Tatsuhiko Igarashi Japan	34	1.9k 1.5×	930 0.8×	1.3k 1.6×	486 0.6×	2.6k 4.0×	94	3.6k
Laura V. Chalifoux United States	27	1.6k 1.3×	1.1k 0.9×	1.2k 1.5×	246 0.3×	2.5k 3.7×	49	3.5k
Luis D. Giavedoni United States	30	1.1k 0.8×	1.1k 0.9×	819 1.0×	322 0.4×	1.1k 1.7×	81	2.8k
Saverio Capuano United States	24	885 0.7×	1.2k 1.0×	1.3k 1.6×	563 0.7×	447 0.7×	54	2.6k
Cedric Mims United Kingdom	33	819 0.7×	1.2k 1.0×	1.0k 1.3×	258 0.3×	239 0.4×	99	2.8k
Michael K. Axthelm United States	37	2.6k 2.1×	2.5k 2.1×	1.4k 1.8×	702 0.9×	2.5k 3.8×	118	5.7k
Shelly J. Robertson United States	28	761 0.6×	438 0.4×	1.2k 1.4×	329 0.4×	280 0.4×	42	2.2k
Rory D. de Vries Netherlands	36	1.2k 0.9×	2.3k 1.9×	1.9k 2.3×	640 0.8×	407 0.6×	116	4.1k
David I. Watkins United States	36	3.3k 2.6×	1.0k 0.8×	945 1.2×	741 0.9×	3.1k 4.7×	79	4.7k
Louis N. Martin United States	27	1.0k 0.8×	977 0.8×	845 1.0×	388 0.5×	1.7k 2.6×	60	2.6k

Countries citing papers authored by John Cruz

Since Specialization

Citations

This map shows the geographic impact of John Cruz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Cruz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Cruz more than expected).

Fields of papers citing papers by John Cruz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Cruz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Cruz. The network helps show where John Cruz may publish in the future.

Co-authorship network of co-authors of John Cruz

This figure shows the co-authorship network connecting the top 25 collaborators of John Cruz. A scholar is included among the top collaborators of John Cruz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Cruz. John Cruz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nanaware, Padma P., John Cruz, Khaja Muneeruddin, Scott A. Shaffer, & Lawrence J. Stern. (2023). Inhibited MHC Class I and MHC Class II antigen processing and presentation upon Sars-CoV-2 infection. The Journal of Immunology. 210(Supplement_1). 222.02–222.02. 1 indexed citations

Chang, Ching‐Wen, Krishna Mohan Parsi, Mohan Somasundaran, et al.. (2022). A Newly Engineered A549 Cell Line Expressing ACE2 and TMPRSS2 Is Highly Permissive to SARS-CoV-2, Including the Delta and Omicron Variants. Viruses. 14(7). 1369–1369. 27 indexed citations

Calvo‐Calle, J. Mauricio, Padma P. Nanaware, John Cruz, et al.. (2022). Broadly recognized, cross-reactive SARS-CoV-2 CD4 T cell epitopes are highly conserved across human coronaviruses and presented by common HLA alleles. Cell Reports. 39(11). 110952–110952. 18 indexed citations

Humphries, Fiachra, Liraz Shmuel-Galia, Zhaozhao Jiang, et al.. (2021). A diamidobenzimidazole STING agonist protects against SARS-CoV-2 infection. Science Immunology. 6(59). 115 indexed citations

López, Luis Felipe, et al.. (2020). Measurement of Neuropeptide Y Using Aptamer-Modified Microelectrodes by Electrochemical Impedance Spectroscopy. Analytical Chemistry. 93(2). 973–980. 24 indexed citations

Dunand, Carole J. Henry, Paul E. Leon, Min Huang, et al.. (2016). Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection. Cell Host & Microbe. 19(6). 800–813. 209 indexed citations

Terajima, Masanori, Mary Dawn T. Co, John Cruz, & Francis A. Ennis. (2015). High Antibody-Dependent Cellular Cytotoxicity Antibody Titers to H5N1 and H7N9 Avian Influenza A Viruses in Healthy US Adults and Older Children. The Journal of Infectious Diseases. 212(7). 1052–1060. 53 indexed citations

Co, Mary Dawn T., Masanori Terajima, Stephen J. Thomas, et al.. (2014). Relationship of Preexisting Influenza Hemagglutination Inhibition, Complement-Dependent Lytic, and Antibody-Dependent Cellular Cytotoxicity Antibodies to the Development of Clinical Illness in a Prospective Study of A(H1N1)pdm09 Influenza in Children. Viral Immunology. 27(8). 375–382. 41 indexed citations

Jameson, Julie, John Cruz, Anne Costanzo, Masanori Terajima, & Francis A. Ennis. (2010). A role for the mevalonate pathway in the induction of subtype cross-reactive immunity to influenza A virus by human γδ T lymphocytes. Cellular Immunology. 264(1). 71–77. 33 indexed citations

10.

Babon, Jenny Aurielle B., John Cruz, Pamela Pazoles, et al.. (2009). Genome-wide screening of human T-cell epitopes in influenza A virus reveals a broad spectrum of CD4+ T-cell responses to internal proteins, hemagglutinins, and neuraminidases. Human Immunology. 70(9). 711–721. 56 indexed citations

11.

Terajima, Masanori, Anita Leporati, Pamela Pazoles, et al.. (2008). Vaccinia virus-specific CD8+ T-cell responses target a group of epitopes without a strong immunodominance hierarchy in humans. Human Immunology. 69(12). 815–825. 21 indexed citations

12.

Co, Mary Dawn T., John Cruz, Pamela Pazoles, et al.. (2008). Discordance between antibody and T cell responses in recipients of trivalent inactivated influenza vaccine. Vaccine. 26(16). 1990–1998. 29 indexed citations

13.

Co, Mary Dawn T., John Cruz, Pamela Pazoles, et al.. (2008). In vitro evidence that commercial influenza vaccines are not similar in their ability to activate human T cell responses. Vaccine. 27(2). 319–327. 44 indexed citations

14.

Terajima, Masanori, John Cruz, Anita Leporati, et al.. (2006). Identification of Vaccinia CD8+ T-Cell Epitopes Conserved among Vaccinia and Variola Viruses Restricted by Common MHC Class I Molecules, HLA-A2 or HLA-B7. Human Immunology. 67(7). 512–520. 30 indexed citations

15.

Kennedy, Jeffrey S., Sharon E. Frey, Lihan Yan, et al.. (2004). Induction of Human T Cell–Mediated Immune Responses after Primary and Secondary Smallpox Vaccination. The Journal of Infectious Diseases. 190(7). 1286–1294. 62 indexed citations

16.

Terajima, Masanori, John Cruz, Elizabeth D. Kilpatrick, et al.. (2003). Quantitation of CD8+ T Cell Responses to Newly Identified HLA-A*0201–restricted T Cell Epitopes Conserved Among Vaccinia and Variola (Smallpox) Viruses. The Journal of Experimental Medicine. 197(7). 927–932. 97 indexed citations

17.

Weltzin, Richard, Jian Liu, К. В. Пугачев, et al.. (2003). Clonal vaccinia virus grown in cell culture as a new smallpox vaccine. Nature Medicine. 9(9). 1125–1130. 118 indexed citations

18.

Terajima, Masanori, et al.. (1999). High-Yield Reassortant Influenza Vaccine Production Virus Has a Mutation at an HLA-A 2.1-Restricted CD8+ CTL Epitope on the NS1 Protein. Virology. 259(1). 135–140. 9 indexed citations

19.

Jameson, Julie, John Cruz, & Francis A. Ennis. (1998). Human Cytotoxic T-Lymphocyte Repertoire to Influenza A Viruses. Journal of Virology. 72(11). 8682–8689. 156 indexed citations

20.

Ennis, F A, John Cruz, Christina F. Spiropoulou, et al.. (1997). Hantavirus Pulmonary Syndrome: CD8+and CD4+Cytotoxic T Lymphocytes to Epitopes on Sin Nombre Virus Nucleocapsid Protein Isolated during Acute Illness. Virology. 238(2). 380–390. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact